On Nov. 19, 2019, Novo Ventures and the Broad Institute of MIT and Harvard announced the launch of the Novo Broad Greenhouse a joint initiative to discover and propel transformative new therapies from academic science into the clinic, and to drive the development of the next generation of molecular medicines.